BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 23535675)

  • 1. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience.
    Ho M; Liu DT; Chong KK; Ng HK; Lam DS
    Hong Kong Med J; 2013 Apr; 19(2):150-5. PubMed ID: 23535675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.
    Cook BE; Bartley GB
    Ophthalmology; 1999 Apr; 106(4):746-50. PubMed ID: 10201597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid tumors in Siriraj Hospital from 2000-2004.
    Pornpanich K; Chindasub P
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S11-4. PubMed ID: 16681045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant eyelid tumors in Hong Kong 1997-2009.
    Mak ST; Wong AC; Io IY; Tse RK
    Jpn J Ophthalmol; 2011 Nov; 55(6):681-5. PubMed ID: 21842179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant eyelid tumours in Taiwan.
    Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
    Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological study of eyelid malignancies from central India.
    Jahagirdar SS; Thakre TP; Kale SM; Kulkarni H; Mamtani M
    Indian J Ophthalmol; 2007; 55(2):109-12. PubMed ID: 17322599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent sebaceous gland carcinoma of eyelid previously diagnosed as basal cell carcinoma: case report.
    Kan LW; Leu YS; Tzen CY; Wu CH
    Am J Otolaryngol; 2011; 32(6):620-3. PubMed ID: 21168242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumours of eyelid: a clinicopathologic study.
    Abdi U; Tyagi N; Maheshwari V; Gogi R; Tyagi SP
    J Indian Med Assoc; 1996 Nov; 94(11):405-9, 416, 418. PubMed ID: 9141864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of eyelid lesions in Sri Lanka.
    Nanayakkara DPS; Dissanayake MM; Gunaratne MP; Soysa VK; Mathangasinghe Y
    Int Ophthalmol; 2023 Jul; 43(7):2513-2519. PubMed ID: 36881193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms.
    Margo CE; Mulla ZD
    Arch Ophthalmol; 1998 Feb; 116(2):195-8. PubMed ID: 9488271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of benign and malignant lesions of eyelid and conjunctival tumors].
    Obata H; Aoki Y; Kubota S; Kanai N; Tsuru T
    Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):573-9. PubMed ID: 16218435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of eyelid malignancy in a Tertiary Health Care Center in North India.
    Gupta P; Gupta RC; Khan L
    J Cancer Res Ther; 2017; 13(3):484-486. PubMed ID: 28862213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collision sebaceous and basal cell carcinomas of the eyelid.
    Levy J; Cagnano E; Benharroch D; Monos T; Lifshitz T
    Ann Diagn Pathol; 2006 Jun; 10(3):157-9. PubMed ID: 16730311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eyelid Tumors at the University Eye Clinic of Ioannina, Greece: A 30-year Retrospective Study.
    Asproudis I; Sotiropoulos G; Gartzios C; Raggos V; Papoudou-Bai A; Ntountas I; Katsanos A; Tatsioni A
    Middle East Afr J Ophthalmol; 2015; 22(2):230-2. PubMed ID: 25949083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.
    Cook BE; Bartley GB
    Ophthalmology; 2001 Nov; 108(11):2088-98; quiz 2099-100, 2121. PubMed ID: 11713084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using American Joint Committee on Cancer Classification criteria for staging eyelid carcinomas.
    Shinder R; Ivan D; Seigler D; Dogan S; Esmaeli B
    Orbit; 2011 Oct; 30(5):202-7. PubMed ID: 21957948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant tumor of the eyelid--clinical survey during 22-year period.
    Abe M; Ohnishi Y; Hara Y; Shinoda Y; Jingu K
    Jpn J Ophthalmol; 1983; 27(1):175-84. PubMed ID: 6855011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological analysis of malignant eyelid tumours in north-west Pakistan.
    Hussain I; Khan FM; Alam M; Khan BS
    J Pak Med Assoc; 2013 Jan; 63(1):25-7. PubMed ID: 23865127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological characteristics of malignant eyelid tumors at a referral hospital in Japan.
    Goto H; Yamakawa N; Komatsu H; Asakage M; Tsubota K; Ueda SI; Nemoto R; Shibata M; Umazume K; Usui Y; Mori H
    Jpn J Ophthalmol; 2022 Jul; 66(4):343-349. PubMed ID: 35670924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of eyelid cancers in Taiwan: a 21-year review.
    Lin HY; Cheng CY; Hsu WM; Kao WH; Chou P
    Ophthalmology; 2006 Nov; 113(11):2101-7. PubMed ID: 16962174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.